PSNL
Personalis, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Buy
+32/100
Last price
16.20
▼ 0.20 (1.24%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
16.48
Prev close
16.40
Day high
16.58
Day low
15.85
Volume
5.66M
Market cap
$1.71B
P/E (TTM)
—
52W range
4.96 – 18.89
Day trading desk
Gap from prior close
+0.49%
Prior close 16.40
VWAP
16.01
+1.16% from price
Relative volume
1.55×
Unusually busy
Session range
13.56%
15.85 – 18.00
Position in range
16%
Near session low
ATR (14D)
0.40
2.49% of price
Prior day high
16.47
PDH
Prior day low
16.02
PDL
Bid / ask spread
—
Quote not published
Session volume
5.52M
Avg 3.56M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.96%
-3.9%
1M
-6.80%
-8.0%
3M
+13.61%
+9.1%
6M
+159.81%
+141.6%
YTD
+101.38%
+87.1%
1Y
+118.39%
+102.0%
3Y
+1,224.79%
+1,142.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PSNL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+27.29K
Net buying
Buy transactions
15
578.78K shares
Sell transactions
12
551.49K shares
Net transactions
+27
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
27.92M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 18, 26 | CHEN RICHARD President |
SELL | 4.00K | $64.85K | Direct |
| Sep 18, 26 | MOORE STEPHEN MICHAEL Officer |
SELL | 2.07K | $33.54K | Direct |
| Sep 18, 26 | TACHIBANA AARON Chief Operating Officer |
SELL | 2.93K | $47.54K | Direct |
| Sep 18, 26 | HALL CHRISTOPHER M. Chief Executive Officer |
SELL | 7.46K | $120.98K | Direct |
| Jul 15, 26 | CHEN RICHARD President |
CONVERSION | 100.00K | $244.00K | Direct |
| Jul 15, 26 | CHEN RICHARD President |
SELL | 100.00K | $1.51M | Direct |
| Jul 9, 26 | HALL CHRISTOPHER M. Chief Executive Officer |
CONVERSION | 100.00K | $161.00K | Direct |
| Jul 9, 26 | HALL CHRISTOPHER M. Chief Executive Officer |
SELL | 100.00K | $1.51M | Direct |
| Jun 29, 26 | TACHIBANA AARON Chief Operating Officer |
CONVERSION | 4.98K | $26.50K | Direct |
| Jun 29, 26 | TACHIBANA AARON Chief Operating Officer |
SELL | 4.98K | $69.75K | Direct |
| Jun 26, 26 | TACHIBANA AARON Chief Operating Officer |
CONVERSION | 51.25K | $383.37K | Direct |
| Jun 26, 26 | HALL CHRISTOPHER M. Chief Executive Officer |
CONVERSION | 100.00K | $161.00K | Direct |
| Jun 26, 26 | TACHIBANA AARON Chief Operating Officer |
SELL | 51.25K | $675.49K | Direct |
| Jun 26, 26 | HALL CHRISTOPHER M. Chief Executive Officer |
SELL | 100.00K | $1.31M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLOOM OLIVIA KYUSUK |
Director | 27.27K | Stock Award(Grant) |
BOWMAN ARTHUR BLAINE |
Director | 19.76K | Stock Award(Grant) |
CHEN RICHARD |
President | 169.88K | Sale |
EASTHAM KARIN |
Director | 19.76K | Stock Award(Grant) |
HALL CHRISTOPHER M. |
Chief Executive Officer | 228.53K | Sale |
MOORE STEPHEN MICHAEL |
Officer | 90.26K | Sale |
MYERS WOODROW A JR |
Director | 32.37K | Stock Award(Grant) |
SHOFF LONNIE |
Director | 37.19K | Stock Award(Grant) |
TACHIBANA AARON |
Chief Operating Officer | 195.90K | Sale |
TEMPUS AI INC |
Beneficial Owner of more than 10% of a Class of Security | 13.04M | Purchase |
Fundamentals
Market cap$1.71B
Enterprise value$1.54B
Revenue (TTM)$69.67M
Gross profit$8.84M
EBITDA$-104.60M
Net income$-107.18M
EPS (TTM)$-1.06
Free cash flow$-56.03M
Total cash$212.66M
Total debt$38.00M
Book value / share$2.21
Shares outstanding106.80M
Float86.37M
Short % of float12.09%
Dividend yield0.00%
Beta (5Y)2.32
Valuation & profitability ratios
Trailing P/E—
Forward P/E-17.05
PEG ratio—
Price / sales—
Price / book7.25
EV / revenue22.07
EV / EBITDA-14.70
Gross margin12.69%
Operating margin-150.25%
Profit margin-153.84%
Return on equity-50.32%
Return on assets-25.03%
Debt / equity16.16
Current ratio5.28
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $69.65M | $84.61M | $73.48M | $65.05M | -17.7% |
| Operating revenue | $68.33M | $84.49M | $73.08M | $64.64M | -19.1% |
| Cost of revenue | $53.87M | $57.79M | $55.27M | $51.70M | -6.8% |
| Gross profit | $15.78M | $26.82M | $18.21M | $13.35M | -41.2% |
| Research & development | $50.26M | $48.91M | $64.78M | $64.91M | +2.8% |
| Selling, general & admin | $53.57M | $46.19M | $49.73M | $63.97M | +16.0% |
| Total operating expense | $103.83M | $95.09M | $114.50M | $128.88M | +9.2% |
| Operating income | -$88.06M | -$68.27M | -$96.29M | -$115.53M | -29.0% |
| Net interest income | $6.95M | $5.49M | $5.79M | $2.19M | +26.7% |
| Pre-tax income | -$81.25M | -$81.27M | -$108.21M | -$113.28M | +0.0% |
| Tax provision | $21.00K | $18.00K | $83.00K | $40.00K | +16.7% |
| Net income | -$81.27M | -$81.28M | -$108.30M | -$113.31M | +0.0% |
| Net income to common | -$81.27M | -$81.28M | -$108.30M | -$113.31M | +0.0% |
| Basic EPS | -0.91 | -1.37 | -2.25 | -2.48 | +33.6% |
| Diluted EPS | -0.91 | -1.37 | -2.25 | -2.48 | +33.6% |
| EBIT | -$81.04M | -$81.24M | -$108.10M | -$113.07M | +0.2% |
| EBITDA | -$71.00M | -$70.30M | -$96.81M | -$104.64M | -1.0% |
| Basic shares | 89.24M | 59.25M | 48.18M | 45.70M | +50.6% |
| Diluted shares | 89.24M | 59.25M | 48.18M | 45.70M | +50.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $124.25M | $91.42M | $56.98M | $89.13M | +35.9% |
| Cash & short-term investments | $239.95M | $185.01M | $114.18M | $167.66M | +29.7% |
| Accounts receivable | $16.20M | $8.14M | $17.73M | $16.64M | +99.1% |
| Inventory | $5.26M | $3.98M | $5.66M | $6.38M | +32.2% |
| Total current assets | $267.95M | $203.01M | $146.74M | $199.70M | +32.0% |
| Property, plant & equipment | $59.93M | $64.73M | $75.22M | $88.42M | -7.4% |
| Total assets | $334.16M | $270.27M | $225.10M | $292.70M | +23.6% |
| Total current liabilities | $39.63M | $31.13M | $47.23M | $33.13M | +27.3% |
| Current debt | $1.19M | $1.67M | $1.65M | $2.22M | -28.7% |
| Total debt | $39.95M | $44.25M | $47.73M | $48.65M | -9.7% |
| Total liabilities | $72.98M | $67.31M | $95.66M | $74.56M | +8.4% |
| Retained earnings | -$631.26M | -$549.99M | -$468.71M | -$360.41M | -14.8% |
| Shareholder equity | $261.19M | $202.96M | $129.44M | $218.14M | +28.7% |
| Working capital | $228.32M | $171.89M | $99.51M | $166.57M | +32.8% |
| Net tangible assets | $261.19M | $202.96M | $129.44M | $218.14M | +28.7% |
| Shares issued | 102.48M | 85.17M | 50.48M | 46.71M | +20.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$81.27M | -$81.28M | -$108.30M | -$113.31M | +0.0% |
| Depreciation & amortisation | $10.05M | $10.94M | $11.30M | $8.43M | -8.2% |
| Stock-based compensation | $9.43M | $10.69M | $14.05M | $19.43M | -11.8% |
| Change in working capital | -$10.19M | -$2.59M | $13.48M | $10.61M | -293.2% |
| Operating cash flow | -$74.95M | -$45.15M | -$56.26M | -$70.23M | -66.0% |
| Capital expenditure | -$4.50M | -$1.60M | -$10.91M | -$49.90M | -181.0% |
| Investing cash flow | -$22.57M | -$35.07M | $13.10M | $52.54M | +35.6% |
| Financing cash flow | $130.34M | $114.67M | $11.03M | $1.37M | +13.7% |
| Free cash flow | -$79.45M | -$46.75M | -$67.17M | -$120.13M | -69.9% |
| End cash position | $126.03M | $93.20M | $58.77M | $90.92M | +35.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $22.36M | $15.47M | $17.34M | $14.49M | $17.20M | +44.5% |
| Operating revenue | $22.33M | $15.05M | $16.23M | $14.40M | $17.11M | +48.4% |
| Cost of revenue | $17.61M | $15.19M | $15.45M | $12.58M | $12.45M | +16.0% |
| Gross profit | $4.74M | $281.00K | $1.90M | $1.91M | $4.76M | +1,587.9% |
| Research & development | $16.34M | $14.54M | $13.07M | $12.17M | $12.38M | +12.4% |
| Selling, general & admin | $22.00M | $17.90M | $14.09M | $13.03M | $14.18M | +22.9% |
| Total operating expense | $38.33M | $32.44M | $27.17M | $25.20M | $26.56M | +18.2% |
| Operating income | -$33.59M | -$32.16M | -$25.27M | -$23.29M | -$21.80M | -4.4% |
| Net interest income | $1.93M | $2.13M | $1.50M | $1.62M | $1.83M | -9.2% |
| Pre-tax income | -$31.68M | -$30.02M | -$23.80M | -$21.65M | -$20.05M | -5.5% |
| Tax provision | $5.00K | $16.00K | $9.00K | $3.00K | $2.00K | -68.8% |
| Net income | -$31.68M | -$30.03M | -$23.81M | -$21.65M | -$20.06M | -5.5% |
| Net income to common | -$31.68M | -$30.03M | -$23.81M | -$21.65M | -$20.06M | -5.5% |
| Basic EPS | -0.30 | -0.29 | -0.26 | -0.24 | -0.23 | -3.4% |
| Diluted EPS | -0.30 | -0.29 | -0.26 | -0.24 | -0.23 | -3.4% |
| EBIT | -$31.64M | -$29.97M | -$23.74M | -$21.59M | -$20.01M | -5.6% |
| EBITDA | -$29.23M | -$27.60M | -$21.28M | -$19.12M | -$17.48M | -5.9% |
| Basic shares | 105.42M | 104.19M | 92.28M | 88.70M | 88.52M | +1.2% |
| Diluted shares | 105.42M | 104.19M | 92.28M | 88.70M | 88.52M | +1.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $93.97M | $73.59M | $124.25M | $49.97M | $53.37M | +27.7% |
| Cash & short-term investments | $212.66M | $233.22M | $239.95M | $150.51M | $173.23M | -8.8% |
| Accounts receivable | $15.10M | $13.02M | $16.20M | $14.38M | $9.95M | +16.0% |
| Inventory | $7.75M | $5.25M | $5.26M | $3.73M | $4.56M | +47.4% |
| Total current assets | $245.05M | $258.20M | $267.95M | $174.40M | $193.34M | -5.1% |
| Property, plant & equipment | $63.43M | $63.40M | $59.93M | $62.25M | $61.47M | +0.1% |
| Total assets | $312.13M | $325.39M | $334.16M | $242.84M | $258.68M | -4.1% |
| Total current liabilities | $46.38M | $39.05M | $39.63M | $36.16M | $31.72M | +18.8% |
| Current debt | $898.00K | $879.00K | $1.19M | $1.47M | $1.86M | +2.2% |
| Total debt | $38.00M | $38.78M | $39.95M | $41.03M | $42.44M | -2.0% |
| Total liabilities | $76.97M | $70.63M | $72.98M | $71.42M | $67.85M | +9.0% |
| Retained earnings | -$692.98M | -$661.29M | -$631.26M | -$607.45M | -$585.80M | -4.8% |
| Shareholder equity | $235.16M | $254.76M | $261.19M | $171.41M | $190.83M | -7.7% |
| Working capital | $198.67M | $219.15M | $228.32M | $138.25M | $161.62M | -9.3% |
| Net tangible assets | $235.16M | $254.76M | $261.19M | $171.41M | $190.83M | -7.7% |
| Shares issued | 106.37M | 104.69M | 102.48M | 88.75M | 88.65M | +1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$31.68M | -$30.03M | -$23.81M | -$21.65M | -$20.06M | -5.5% |
| Depreciation & amortisation | $2.41M | $2.37M | $2.46M | $2.47M | $2.53M | +1.8% |
| Stock-based compensation | $3.98M | $2.55M | $2.30M | $2.08M | $2.83M | +55.9% |
| Change in working capital | $453.00K | $3.57M | -$2.41M | -$4.20M | $2.37M | -87.3% |
| Operating cash flow | -$25.77M | -$22.48M | -$22.25M | -$21.80M | -$12.94M | -14.6% |
| Capital expenditure | -$3.78M | -$3.19M | -$77.00K | -$1.63M | -$290.00K | -18.5% |
| Investing cash flow | $38.16M | -$46.01M | -$14.38M | $18.72M | -$4.37M | +182.9% |
| Financing cash flow | $7.99M | $17.83M | $110.89M | -$317.00K | -$327.00K | -55.2% |
| Free cash flow | -$29.55M | -$25.67M | -$22.32M | -$23.43M | -$13.22M | -15.1% |
| End cash position | $95.76M | $75.38M | $126.03M | $51.76M | $55.16M | +27.0% |
Options analytics
Put / call volume
3.23
Put-heavy session
Put / call open interest
0.10
Positioning, not flow
Max pain
12.50
-22.0% from spot
ATM implied vol
64.6%
Nearest strike to spot
Skew (10% OTM)
+12.5%
Puts bid over calls
Call volume
71
Contracts, this expiry
Put volume
229
Contracts, this expiry
Heaviest call OI
17.50
5.25K contracts
Heaviest put OI
15.00
486 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.28 | -0.30 | -9.1% |
| Mar 2026 | -0.28 | -0.29 | -2.7% |
| Dec 2025 | -0.29 | -0.26 | +8.8% |
| Sep 2025 | -0.27 | -0.24 | +12.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.25 | 6 | $21.40M | +47.6% |
| Next quarter | -0.24 | 6 | $24.55M | +41.5% |
| Current year | -1.08 | 5 | $82.47M | +18.4% |
| Next year | -0.94 | 7 | $109.24M | +32.5% |
Analyst targets & ownership
Mean target$15.44
High target$16.25
Low target$13.00
Implied upside-4.69%
Analyst count4
ConsensusNONE
Strong buy / Buy0 / 2
Hold3
Sell / Strong sell0 / 0
Held by insiders26.15%
Held by institutions66.82%
Institutions holding223
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
16.32
-0.76% from price
SMA 20
16.29
-1.62% from price
SMA 50
15.57
+2.97% from price
SMA 100
13.50
+19.99% from price
SMA 200
10.61
+51.04% from price
EMA 12
16.29
-0.55% from price
EMA 26
16.17
+0.14% from price
EMA 50
15.46
+4.74% from price
RSI (14)
47.7
Neutral
MACD (12,26,9)
0.11
Hist -0.09
ATR (14)
0.40
2.52% of price
Realised vol 30D
20.5%
Annualised
Bollinger upper
16.55
20, 2σ
Bollinger lower
16.04
20, 2σ
50 / 200 cross
Golden
15.57 vs 10.61
Trend bias
Above 200
+51.04%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.75
More volatile than market
Correlation to SPY
0.39
Loosely linked
Realised vol 30D
20.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-55.2%
Peak to trough
Max drawdown 5Y
-95.6%
Peak to trough
ATR 14
0.40
2.52% of price
Beta (reported)
2.32
5Y monthly, from filing
Short interest
Shares short
8.27M
Prior 8.40M
Change vs prior
-1.6%
Shorts covering
% of float
12.09%
Elevated
% of shares out
7.74%
Against total outstanding
Days to cover
2.3
Liquid
Float
86.37M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | BTIG | DOWNGRADE | Buy | Neutral |
| Jul 20, 26 | Lake Street | DOWNGRADE | Buy | Hold |
| Jul 20, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 20, 26 | Needham | DOWNGRADE | Buy | Hold |
| Jul 17, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 9, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| May 12, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| May 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 5, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 27, 26 | Needham | MAINTAINED | Buy | Buy |
| Feb 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jan 26, 26 | Guggenheim | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Tender Offer/Acquisition Reports
SC 13E3/A · 2026-10-02
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-15
Tender Offer/Acquisition Reports
SC 13E3 · 2026-08-31
Corporate Changes & Voting Matters
8-K · 2026-08-20
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-07-20
Corporate Changes & Voting Matters
8-K · 2026-05-20
Corporate Changes & Voting Matters
8-K · 2026-05-13
Headlines
BTIG Downgrades Personalis to Neutral From Buy
MT Newswires · 16h ago
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
MarketBeat · 15d ago
Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak
Barrons.com · 19d ago
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.
The Wall Street Journal · 33d ago
Piper Sandler Lifts Tempus AI to Overweight at $76
GuruFocus.com · 36d ago
Tempus AI shares rise 2.7% following analyst actions
InvestorsHub · 36d ago
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
Insider Monkey · 40d ago
Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next.
Barchart · 41d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.